NCT06190860

Brief Summary

Bone healing is affected by smoking, particularly healing of extraction sockets, showing deficiencies in vertical and horizontal bone dimensions compared to the healing of non-smokers. Several approaches have been made to stimulate. Bone wound healing, including human autologous blood-derived fractions. One of these fractions is the leukocyte platelet-rich fibrin (L-PRF). L-PRF has been evidenced as potentially beneficial in promoting bone defect filling in alveolar bone and socket preservation in non-smokers. However, scarce evidence is related to this beneficial effect in smokers. This clinical trial aims to study and compare the in vivo effects of L-PRF during bone wound healing and regeneration in smokers. The main question is: Has the L-PRF a beneficial effect during alveolar ridge preservation in smokers? After consent, participants with tooth extraction indications and implant rehabilitation treatment will be enrolled. After randomization, participants will be assigned to an experimental group treated with L-PRF plugs and membranes or a control group (physiological healing). Participants will receive two interventions:

  • First intervention: Tooth extraction, intraoral scan, and Cone Beam Computed Tomography in the treated zone.
  • Second intervention (4 months after first intervention): intraoral scan and Cone Beam Computed Tomography in the treated zone

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 19, 2023

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

January 5, 2024

Status Verified

December 1, 2023

Enrollment Period

1.6 years

First QC Date

December 19, 2023

Last Update Submit

December 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Alveolar ridge changes

    linear changes in horizontal width and vertical height of the alveolar ridge measured in the CBCTs taken immediately after tooth extraction and after four months.

    inmediately after tooth extraction and after four months

Secondary Outcomes (2)

  • Alveolar ridge sof tissue changes

    inmediately after tooth extraction and after four months

  • Tissue healing

    Biopsy at least four months after tooth extraction

Study Arms (2)

Control

OTHER

Post-extraction sockets will be sutured and left to heal spontaneously with physiological blood clot. First intervention: intraoral scan and intraoral scan and Cone Beam Computed Tomography in the treated zone. Clinicians will make a post-surgical control to evaluate how healing will be performed Four months after the first Intervention, participants will recall getting a second scan and Cone Beam Computed Tomography in the treated zone. Images will be used for implant treatment planification. Before implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.

Other: Intraoral ScanRadiation: Computed TomographyOther: Biopsy

L-PRF Treatment

EXPERIMENTAL

Post-extraction sockets will be treated with L-PRF plugs and membranes. First intervention: intraoral scan and intraoral scan and Cone Beam Computed Tomography in the treated zone. Clinicians will make a post-surgical control to evaluate how healing will be performed Four months after the first Intervention, participants will recall getting a second scan and Cone Beam Computed Tomography in the treated zone. Images will be used for implant treatment planification. Before implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.

Other: Autologous Leukocyte and platelet-rich fibrinOther: Intraoral ScanRadiation: Computed TomographyOther: Biopsy

Interventions

Participants will be treated with L-PRF plugs and membranes from autologous venous blood. Participants will have drawn blood after venipuncture (median cubital vein) into sterile, glass-coated plastic 9 mL tubes without anticoagulant. These tubes will be centrifuged at 2700 rpm for 12 min (Relative Centrifugal Forces-clot = 408 g). After tooth extraction, participants in the experimental group will be treated with L-PRF plugs and membranes.

L-PRF Treatment

Intraoral scan will be taken in the treated zone after tooth extraction and after four months.

ControlL-PRF Treatment

Cone Beam Computed Tomography in the treated zone will be taken after tooth extraction and after four months.

ControlL-PRF Treatment
BiopsyOTHER

Before dental implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.

ControlL-PRF Treatment

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Smokers (at least five cigarettes/day) have had the habit for at least one year.
  • treatment plan that includes the indication of extraction of a single, double-rooted, or multi-rooted tooth and prosthetic rehabilitation with osseointegrated implants
  • Patients with controlled systemic pathologies (hypertension, diabetes, hypercholesterolemia).
  • With alveolar bone support of at least 50% and whose indication is delayed implant placement at least four months after extraction.
  • Periapical lesions of no more than 5 mm diameter.

You may not qualify if:

  • patients taking immunosuppressive or anticoagulant drugs
  • pregnant
  • users of removable prostheses
  • Individuals with altered values of platelet count or coagulation parameters.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinical Facility, School of Dentistry, Pontificia Universidad Católica de Chile

Santiago, Santiago Metropolitan, 7820436, Chile

ENROLLING BY INVITATION

Dental facility, Health center at San Bernardo, Faculty of Dentistry, University of the Andes

Santiago, Santiago Metropolitan, 8051285, Chile

RECRUITING

MeSH Terms

Conditions

Alveolar Bone LossCigarette Smoking

Interventions

Biopsy

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesTobacco SmokingSmokingBehaviorTobacco Use

Intervention Hierarchy (Ancestors)

CytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingDiagnostic Techniques, SurgicalSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Constanza Martínez, DDS PhD

    University of the Andes, Chile

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Constanza Martínez, DDS PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2023

First Posted

January 5, 2024

Study Start

May 29, 2022

Primary Completion

December 31, 2023

Study Completion

March 31, 2024

Last Updated

January 5, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

Individual participant data will underlie results in a publication.

Shared Documents
STUDY PROTOCOL, CSR

Locations